Abivax S.A. buy DerAlmanach100000
Start price
02.06.26
/
50%
€66.60
Target price
02.06.27
-
Performance (%)
6.08%
End price
03.06.26
€70.65
Summary
This prediction ended on 03.06.26 with a price of €70.65. The BUY prediction by DerAlmanach100000 finished with a performance of 6.08%. DerAlmanach100000 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abivax S.A. | - | - |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
According to DerAlmanach100000 what are the pros and cons of Abivax S.A. for the foreseeable future?
Pros
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very high dividend yield expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Abivax S.A. diskutieren
Buy Abivax S.A.
In the thread Trading Abivax S.A.
Stopped prediction by DerAlmanach100000 for Abivax S.A.
Abivax S.A.
Start price
Target price
Perf. (%)
€104.20
24.11.25
24.11.25
-
24.11.28
24.11.28
8.83%
26.11.25
26.11.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Abivax S.A.
Start price
Target price
Perf. (%)
€7.28
08.06.25
08.06.25
-
08.06.28
08.06.28
497.53%
23.07.25
23.07.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued